CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Outcomes and Biomarkers of Immune Checkpoint Inhibitor Therapy in Patients with Refractory Head and Neck Squamous Cell Carcinoma: KCSG HN18-12
Yun-Gyoo Lee, Hyun Chang, Bhumsuk Keam, Sang Hoon Chun, Jihyun Park, Keon Uk Park, Seong Hoon Shin, Ho Jung An, Kyoung Eun Lee, Keun-Wook Lee, Hye Ryun Kim, Sung-Bae Kim, Myung-Ju Ahn, In Gyu Hwang
Cancer Research and Treatment. 2021;53(3):671-677.   Published online 2020 December 7    DOI: https://doi.org/10.4143/crt.2020.824

Excel Download

Outcomes and Biomarkers of Immune Checkpoint Inhibitor Therapy in Patients with Refractory Head and Neck Squamous Cell Carcinoma: KCSG HN18-12
Cancer Research and Treatment. 2021;53(3):671-677   Crossref logo
Link1 Link2 Link3

Treatment sequence of cetuximab and immune checkpoint inhibitor in head and neck squamous cell carcinoma differentially affects outcomes
Oral Oncology. 2020;111:105024   Crossref logo
Link1 Link2

Immune checkpoint inhibitors for head and neck squamous cell carcinoma: Current landscape and future directions
Head & Neck. 2019;41(S1):4-18   Crossref logo
Link1 Link2 Link3 Link4

Biomarkers for Immune Modulatory Treatment in Head and Neck Squamous Cell Carcinoma (HNSCC)
Critical Issues in Head and Neck Oncology. 2021;83-91   Crossref logo
Link1

357. Biomarkers Predict p53 Gene Therapy Efficacy in Recurrent, Squamous Cell Carcinoma of the Head and Neck
Molecular Therapy. 2009;17:S139   Crossref logo
Link1 Link2

Immune biomarkers of response to immune-checkpoint inhibitors in head and neck squamous cell carcinoma
Annals of Oncology. 2019;30(1):57-67   Crossref logo
Link1 Link2 Link3

Exploration of Feasible Immune Biomarkers for Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma Treatment in Real World Clinical Practice
International Journal of Molecular Sciences. 2020;21(20):7621   Crossref logo
Link1

Advances in T-cell checkpoint immunotherapy for head and neck squamous cell carcinoma
OncoTargets and Therapy. 2017;Volume 10:5745-5754   Crossref logo
Link1 Link2

Insulin-like growth factor-1 receptor inhibitor, AMG-479, in cetuximab-refractory head and neck squamous cell carcinoma
Head & Neck. 2010;33(12):1804-1808   Crossref logo
Link1 Link2

Immune checkpoint pathways in immunotherapy for head and neck squamous cell carcinoma
International Journal of Oral Science. 2020;12(1):   Crossref logo
Link1 Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.